Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Senate advances sweeping energy legislation in first major action since midterm elections

    November 22, 2026

    The Expedia breach shows why companies must stop holding data they do not need | Fortune

    November 22, 2026

    You Can See Everything review – stranger than fiction

    November 22, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Science»The Search for Long Covid Treatments Takes a Promising Turn | WIRED
    Science

    The Search for Long Covid Treatments Takes a Promising Turn | WIRED

    By AdminApril 20, 2023
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    The Search for Long Covid Treatments Takes a Promising Turn
| WIRED

    [ad_1]

    Three years in, the pandemic mania has settled to a rumbling hum. We’re back to sweating on each other in nightclubs, spluttering out birthday candles, and sharing firm handshakes. Covid-19, while still very much alive, has for most people diminished to an everyday threat, thanks to vaccines and treatments.

    The same can’t be said of long Covid, the mysterious, life-limiting ailment that lingers on after an initial Covid infection. For the millions besieged by it, their situation has remained much the same. “We still have no established tools to help treat patients,” says Linda Geng, codirector of the Post-Acute Covid-19 Syndrome Clinic at Stanford University. Estimates of how many people have long Covid vary, but it’s been put as high as around 65 million—about the same as the population of France.

    It’s only now, over three years into the pandemic, that a consensus on what long Covid is has started to solidify. And what it is, it turns out, is a whole bunch of things. Rather than a single disorder, it’s more likely a smorgasbord of diseases that fall under one big umbrella. That means there likely won’t be a one-size-fits-all treatment either.

    What triggers long Covid for you may not be what sets it off for another. Perhaps your long Covid is caused by your immune system turning on you, attacking your body—a phenomenon called autoimmunity. So goes one theory. Or maybe it’s that splinters of the virus are hanging around your body long after the initial infection, keeping your immune system’s engine revved up to the point of exhaustion. Another theory is that SARS-CoV-2 causes long-lasting damage to certain organs or tissues. Maybe it’s that a Covid infection reawakens latent viruses your body has encountered before, such as the Epstein-Barr virus, which causes mononucleosis.

    All these theories have some evidence to support them, and they may not be mutually exclusive; for some people, these things could be happening at the same time. The idea that long Covid has different causes could go some way toward explaining the sheer diversity of symptoms, which number up to 200.

    Working off this basis, researchers are trying to hit two birds with one stone: trialing treatments that could alleviate long Covid while at the same time lending weight to certain hypotheses—and beginning to defog the mystifying condition. “The reality is that there’s such an urgency, we need to do these things in parallel,” says Geng. “It’s building the ship as we sail it—but we have to sail it because people need help.”

    But the jumble of symptoms makes designing clinical trials much trickier. Not every person experiences every symptom, and those may vary in severity and duration. Plus, there’s no consensus on how to define long Covid, says Steven Deeks, a physician and infectious disease specialist at the University of California, San Francisco. “There’s no magic biomarker, there’s no x-ray, there’s no test.” Because of that, it’s tough to figure out who to put into a clinical trial. Right now, long Covid diagnoses work by exclusion: determining that symptoms can’t be explained away by another cause. Regardless, researchers are plowing ahead.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleJessica Chastain Talks Autographs After Viral ‘Evelyn Hugo’ Moment – The Hollywood Reporter
    Next Article The Hacker Who Hijacked Matt Walsh’s Twitter Was Just ‘Bored’

    RELATED POSTS

    Voyager 1 Beat the Odds and Is Still Working a Light-Day Away From Earth

    November 18, 2026

    The Dark Side of the Moon Was the Brightest Part of 2026

    November 17, 2026

    Just 400 US Data Centers Use More Electricity Than Michigan

    November 16, 2026

    The EPAs Chemical-Detecting Plane Isnt Doing Its Job Anymore

    November 16, 2026

    Its Getting Too Dry for Even Cactuses to Survive

    November 15, 2026

    New Species of Giant Fungus Discovered in China Grows up to 20 Inches Tall

    November 15, 2026
    latest posts

    Senate advances sweeping energy legislation in first major action since midterm elections

    WASHINGTON — The Senate on Monday advanced bipartisan legislation aimed at speeding up permitting reviews…

    The Expedia breach shows why companies must stop holding data they do not need | Fortune

    November 22, 2026

    You Can See Everything review – stranger than fiction

    November 22, 2026

    Signal restricts mobile screenshots as it confronts existential threat of AI surveillance | TechCrunch

    November 21, 2026

    Here are the top AI agents that can live in your text messages  | TechCrunch

    November 21, 2026

    You either take the wheel, or were going to run into the wall: The founder who sold Wrike for $2.25 billion forced his engineers to build around AI | Fortune

    November 21, 2026

    Book Riots Deals of the Day for November 21, 2026

    November 21, 2026
    Categories
    • Books (1,622)
    • Business (6,527)
    • Cover Story (17)
    • Film (6,461)
    • Lifestyle (4,501)
    • Music (6,537)
    • Politics (6,513)
    • Science (5,867)
    • Technology (6,465)
    • Television (6,158)
    • Uncategorized (3)
    • US News (6,510)
    popular posts

    Why Hurricane Melissa Was One of the Most Powerful Atlantic Storms in History

    [ad_1] Rachel Feltman: Happy Monday, listeners! For Scientific American’s Science Quickly, I’m Rachel Feltman. Today…

    Even Right-Wingers Think Elon Musk’s Hunter Biden Reveal Is A Nothingburger

    December 4, 2022

    Tom Holland Says He Won’t Host SNL Because Of His Dyslexia

    June 3, 2026

    India’s JioHotstar takes partnership route for Middle East expansion

    October 6, 2026
    Archives
    Browse By Category
    • Books (1,622)
    • Business (6,527)
    • Cover Story (17)
    • Film (6,461)
    • Lifestyle (4,501)
    • Music (6,537)
    • Politics (6,513)
    • Science (5,867)
    • Technology (6,465)
    • Television (6,158)
    • Uncategorized (3)
    • US News (6,510)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    You either take the wheel, or were going to run into the wall: The founder who sold Wrike for $2.25 billion forced his engineers to build around AI | Fortune

    November 21, 2026

    Book Riots Deals of the Day for November 21, 2026

    November 21, 2026

    Startup sues Apple in India over tap-to-share contacts feature | TechCrunch

    November 21, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT